Cite
MLA Citation
Sara Pilotto et al.. “An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer.” Expert opinion on investigational drugs, vol. 24, n.d., pp. 1143–1161. http://access.bl.uk/ark:/81055/vdc_100026107777.0x00004b